Renaissance Technologies’s AIM ImmunoTech AIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,183
| Closed | -$38.9K | – | 4018 |
|
|
2025
Q1 | $38.9K | Buy |
3,183
+576
| +22% | +$9.26K | ﹤0.01% | 3312 |
|
|
2024
Q4 | $51.6K | Buy |
2,607
+172
| +7% | +$4.01K | ﹤0.01% | 3385 |
|
|
2024
Q3 | $65.7K | Buy |
2,435
+145
| +6% | +$4.83K | ﹤0.01% | 3321 |
|
|
2024
Q2 | $85.3K | Buy |
2,290
+80
| +4% | +$3.4K | ﹤0.01% | 3212 |
|
|
2024
Q1 | $104K | Buy |
2,210
+188
| +9% | +$7.79K | ﹤0.01% | 3361 |
|
|
2023
Q4 | $89K | Buy |
2,022
+97
| +5% | +$4.52K | ﹤0.01% | 3335 |
|
|
2023
Q3 | $88K | Buy |
1,925
+135
| +8% | +$8.32K | ﹤0.01% | 3277 |
|
|
2023
Q2 | $120K | Buy |
1,790
+101
| +6% | +$4.87K | ﹤0.01% | 3431 |
|
|
2023
Q1 | $73K | Buy |
1,689
+319
| +23% | +$16.5K | ﹤0.01% | 3582 |
|
|
2022
Q4 | $43K | Buy |
1,370
+120
| +10% | +$5.58K | ﹤0.01% | 3828 |
|
|
2022
Q3 | $73K | Buy |
1,250
+45
| +4% | +$3.15K | ﹤0.01% | 3672 |
|
|
2022
Q2 | $94K | Sell |
1,205
-3,080
| -72% | -$296K | ﹤0.01% | 3869 |
|
|
2022
Q1 | $454K | Sell |
4,285
-2,773
| -39% | -$239K | ﹤0.01% | 3256 |
|
|
2021
Q4 | $649K | Buy |
+7,058
| New | +$1.09M | ﹤0.01% | 2955 |
|
|
2021
Q3 | – | Sell |
-1,530
| Closed | -$329K | – | 4070 |
|
|
2021
Q2 | $329K | Sell |
1,530
-3,262
| -68% | -$699K | ﹤0.01% | 3116 |
|
|
2021
Q1 | $1.09M | Buy |
+4,792
| New | +$1.08M | ﹤0.01% | 2580 |
|
|
2020
Q1 | – | Sell |
-173
| Closed | -$9K | – | 4047 |
|
|
2019
Q4 | $9K | Buy |
+173
| New | +$8.68K | ﹤0.01% | 3466 |
|
|
2018
Q1 | – | Sell |
-6
| Closed | -$9K | – | 3782 |
|
|
2017
Q4 | $9K | Sell |
6
-6
| -50% | -$8.63K | ﹤0.01% | 3301 |
|
|
2017
Q3 | $17K | Sell |
12
-4
| -25% | -$7.02K | ﹤0.01% | 3160 |
|
|
2017
Q2 | $36K | Sell |
16
-14
| -47% | -$34.6K | ﹤0.01% | 3141 |
|
|
2017
Q1 | $73K | Sell |
30
-2
| -6% | -$5.11K | ﹤0.01% | 3116 |
|
|
2016
Q4 | $97K | Sell |
32
-4
| -11% | -$16.1K | ﹤0.01% | 3107 |
|
|
2016
Q3 | $199K | Buy |
36
+2
| +6% | +$14K | ﹤0.01% | 3071 |
|
|
2016
Q2 | $209K | Sell |
34
-1
| -3% | -$6.56K | ﹤0.01% | 3039 |
|
|
2016
Q1 | $246K | Hold |
35
| – | – | ﹤0.01% | 3035 |
|
|
2015
Q4 | $149K | Buy |
35
+9
| +35% | +$61.2K | ﹤0.01% | 3059 |
|
|
2015
Q3 | $238K | Buy |
26
+4
| +18% | +$38.4K | ﹤0.01% | 2859 |
|
|
2015
Q2 | $234K | Buy |
22
+9
| +69% | +$111K | ﹤0.01% | 2946 |
|
|
2015
Q1 | $153K | Buy |
13
+8
| +160% | +$100K | ﹤0.01% | 2948 |
|
|
2014
Q4 | $64K | Buy |
5
+4
| +400% | +$59.7K | ﹤0.01% | 2856 |
|
|
2014
Q3 | $24K | Buy |
+1
| New | +$15.4K | ﹤0.01% | 2739 |
|
|
2014
Q1 | – | Sell |
-2
| Closed | -$30K | – | 3289 |
|
|
2013
Q4 | $30K | Sell |
2
-5
| -71% | -$60.4K | ﹤0.01% | 2805 |
|
|
2013
Q3 | $86K | Buy |
7
+5
| +250% | +$63K | ﹤0.01% | 2703 |
|
|
2013
Q2 | $21K | Buy |
+2
| New | +$23.9K | ﹤0.01% | 2736 |
|
Other funds holding AIM
CB
HI
HI
DB
Renaissance Technologies's AIM Position: Q2 2025 in Review
Renaissance Technologies sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 3,183 shares — an estimated $38.9K sold.
Renaissance Technologies first reported a position in AIM in Q2 2013 and held it in 34 quarters. The position peaked at $1.09M in Q1 2021. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.
- Renaissance Technologies reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
- Renaissance Technologies sold 3,183 AIM ImmunoTech shares in Q2 2025, an estimated $38.9K.
- Renaissance Technologies first reported a position in AIM ImmunoTech in Q2 2013 and held it in 34 quarters.
- Renaissance Technologies's AIM ImmunoTech position peaked at $1.09M in Q1 2021.
- 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.